Encyclopedia of Metagenomics

2015 Edition
| Editors: Sarah K. Highlander, Francisco Rodriguez-Valera, Bryan A. White

Chronic Respiratory Disease, COPD

  • Yvonne Huang
Reference work entry
DOI: https://doi.org/10.1007/978-1-4899-7475-4_698

Synonyms

Airway microbiome in COPD; Microbiota in COPD

Definition

The types, distribution, and environmental interactions of microbial communities present in the lungs of individuals with chronic obstructive pulmonary disease (COPD).

Introduction

Definition of COPD

The purpose of this entry is to introduce and summarize current knowledge of the airway microbiome in chronic obstructive pulmonary disease (COPD), a smoking-related illness. COPD is a highly prevalent disorder characterized by airflow obstruction that is not completely reversible and which exhibits increasing morbidity and mortality (Han et al. 2012). Classically two forms of clinical presentation were defined for COPD: chronic bronchitis and emphysema. Chronic bronchitis is characterized by excessive mucus production that results in airflow obstruction in the proximal airways. Emphysema is characterized by destruction of distal airway spaces in the lung, where gas exchange takes place.

However, COPD is now recognized to be...

This is a preview of subscription content, log in to check access.

References

  1. Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A, Monsó E, Mira A. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol. 2012;50(11):3562–8.PubMedCentralPubMedGoogle Scholar
  2. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the ‘healthy’ smoker and in COPD. PLoS ONE. 2011;6(2):e16384.PubMedCentralPubMedGoogle Scholar
  3. Han MK, Augusti A, Calverly P, et al. Am J Respir Crit Care Med. 2010;2010(182):598–604.Google Scholar
  4. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67(5):456–63.PubMedCentralPubMedGoogle Scholar
  5. Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med. 2011;5(6):809–21.PubMedCentralPubMedGoogle Scholar
  6. Huang YJ, Kim E, Cox MJ, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS. 2010;14(1):9–59.PubMedCentralPubMedGoogle Scholar
  7. Huang YJ, Charlson ES, Collman RG, et al. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med. 2013;187(12):1382–7.PubMedGoogle Scholar
  8. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE. 2012;7(10):e47305. doi:10.1371/journal.pone.0047305Google Scholar
  9. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–65.PubMedGoogle Scholar
  10. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465–71.PubMedGoogle Scholar
  11. Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(5):491–7.PubMedGoogle Scholar
  12. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1073–80.PubMedCentralPubMedGoogle Scholar
  13. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Pulmonary and Critical Care Medicine, School of MedicineUniversity of California San FranciscoSan FranciscoUSA